McGrath Lynne Fahey
- SEC CIK
- 0001866270
In the past year, 1 open-market sale filing worth $68.7 and no purchases.
Current role at each company
- ALZN Alzamend Neuro, Inc.Directoras of Oct 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $68.7
- 1 filing
- Net
- −$68.7
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McGrath Lynne Fahey as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2025 (view filing) | Oct 23 | 1 day | McGrath Lynne FaheyDirector | SSale | −30 | $2.29 | −$68.7 | −54.5%25 after | |
| Mar 23, 2023 (view filing)4:30 PM ET | Mar 22 | 1 day | McGrath Lynne FaheyDirector | PPurchase | +10.0K | $0.435 | +$4.35K | New position10.0K after | |
| Apr 8, 2022 (view filing) | Mar 28 | 11 days | McGrath Lynne FaheyDirector | SSale | −25.0K | $1.21 | −$30.3K | −25.0%75.0K after | Amended |